We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rectangle Image
Product

D614G : SARS-CoV-2 S1 Variant

Rectangle Image
Product

D614G : SARS-CoV-2 S1 Variant

A recent study from Los Alamos National Laboratory has identified a major mutation on SARS-CoV-2 Spike. This D614G mutation has rapidly become dominant in these regions, suggesting this mutation may make the SARS-CoV-2 virus more transmissive. It's critical to understand the biology of this variant, particularly in the context of vaccine and drug design.

Sino Biological has developed a recombinant S1 protein with a D614G mutation (40591-V08H3). The recombinant 614G variant demonstrated an ACE2 binding activity.

In addition to the D614G mutation, several other mutations are also identified. Some of them are believed to enhance S1's ability to bind with ACE2. Sino Biological has developed a panel of mutated RBD proteins to facilitate the study of these variants.

Full List of SARS-CoV-2 Antigens

Company Details
Sino Biological Inc
1400 Liberty Ridge Drive
Suite 101
Wayne
PA
19087
United States
Tel: +1-215-583-7898
Fax: +1-267-657-0217
Advertisement